Galapagos NV ADR (GLPG) had the highest return between October 1, 2014 and May 27, 2015 by a mid-cap US stock, returning 230.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Galapagos NV ADR (GLPG) | 10/1/2014 - 5/27/2015 | 230.07% |
Uranium Energy (UEC) | 10/1/2014 - 5/27/2015 | 121.31% |
Frontline (FRO) | 10/1/2014 - 5/27/2015 | 116.67% |
Corcept Therapeutics (CORT) | 10/1/2014 - 5/27/2015 | 115.99% |
Insperity (NSP) | 10/1/2014 - 5/27/2015 | 108.78% |
Ambarella (AMBA) | 10/1/2014 - 5/27/2015 | 105.91% |
Stonex (SNEX) | 10/1/2014 - 5/27/2015 | 103.11% |
Repligen (RGEN) | 10/1/2014 - 5/27/2015 | 102.71% |
Caesars Entertainment (CZR) | 10/1/2014 - 5/27/2015 | 102.38% |
Amicus Therapeutics (FOLD) | 10/1/2014 - 5/27/2015 | 101.69% |
Agios Pharm (AGIO) | 10/1/2014 - 5/27/2015 | 100.37% |
CleanSpark (CLSK) | 10/1/2014 - 5/27/2015 | 100% |
Halozyme Therapeutics (HALO) | 10/1/2014 - 5/27/2015 | 95.39% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 10/1/2014 - 5/27/2015 | 94.23% |
Skechers (SKX) | 10/1/2014 - 5/27/2015 | 93.82% |
SkyWest (SKYW) | 10/1/2014 - 5/27/2015 | 92.89% |
Dycom Industries (DY) | 10/1/2014 - 5/27/2015 | 91.56% |
Applied Digital (APLD) | 10/1/2014 - 5/27/2015 | 88.52% |
Credit Acceptance (CACC) | 10/1/2014 - 5/27/2015 | 88.02% |
Qorvo (QRVO) | 10/1/2014 - 5/27/2015 | 87.01% |
Ligand Pharmaceuticals (LGND) | 10/1/2014 - 5/27/2015 | 85.3% |
Globant (GLOB) | 10/1/2014 - 5/27/2015 | 84.09% |
Walker & Dunlop (WD) | 10/1/2014 - 5/27/2015 | 83.26% |
Cirrus Logic (CRUS) | 10/1/2014 - 5/27/2015 | 82.94% |
Bausch Health Companies (BHC) | 10/1/2014 - 5/27/2015 | 82.37% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
